Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association. Editor-in-chief, Alan Farwell, MD, FACE
Volume 10 Issue 2
Available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 10 Issue 2 (PDF file, 7.0 MB)
TABLE OF CONTENTS – Web Format
SUBCLINICAL THYROID DYSFUNCTION Subclinical hyperthyroidism, but not subclinical hypothyroidism, is associated with increased dementia risk
Rieben C et al Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies. J Clin Endocrinol Metab. September 30, 2016 [Epub ahead of print].
(PDF File for saving and printing, 558 KB)
HYPOTHYROIDISM Should patient age and gender influence screening for autoimmune hypothyroidism?
Carlé A et al. Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population-based case-control study. Am J Med. July 6, 2016
(PDF File for saving and printing, 571 KB)
THYROID AND PREGNANCY How often is iodine supplementation recommended by U.S. midwives and obstetricians to their patients?
De Leo S et al. Iodine Supplementation in Women During Preconception, Pregnancy, and Lactation: Current Clinical Practice by U.S. Obstetricians and Midwives. Thyroid 2016 (ePub)
(PDF File for saving and printing, 531 KB)
THYROID CANCER The increased incidence of thyroid cancer is worldwide
Wiltshire JJ et al. Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 2016;26:1541-52.
(PDF File for saving and printing, 490 KB)
THYROID CANCER Thyroid cancer over-diagnosis is a result of screening programs in South Korea
Park S et al Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 2016;355:i5745. doi: 10.1136/bmj.i5745.
(PDF File for saving and printing, 583 KB)
THYROID CANCER BRAF-positive thyroid cancer differs from RAS-positive thyroid cancer
Kakarmath S et al Clinical, sonographic, and pathological characteristics of RAS-positive versus BRAFpositive thyroid carcinoma. J Clin Endocrinol Metab 2016;101:4938-44. Epub September 30, 2016.
(PDF File for saving and printing, 495 KB)
ATA ALLIANCE FOR THYROID PATIENT EDUCATION
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.